ClinicalTrials.Veeva

Menu

Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma (MONOMM)

C

Centre Hospitalier Universitaire, Amiens

Status

Enrolling

Conditions

Multiple Myeloma
Monocytes
CART Cells

Study type

Observational

Funder types

Other

Identifiers

NCT07180992
PI2025_843_0130

Details and patient eligibility

About

Tumoral micro-environment in malignant haematological diseases, notably in multiple myeloma, is active on plasma cells survival and proliferation. Monocytosis and monocytes typing are described in multiple myeloma response as factors on proliferation and cell death evasion. CART cells have improved multiple myeloma care in last 5 years, nethertheless, early relapse occur and we must identify predictor factors of better response. The aim of this study is to analyze basic level and phenotyping of monocytes before and after CART cells infusion and study their impact on multiple myeloma response

Enrollment

25 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients over 18 years old
  • Treated for a multiple myeloma
  • CART cells treatment proposed
  • Affiliated to social security system
  • Agreed to participate to the study

Trial contacts and locations

1

Loading...

Central trial contact

Lydia Montes, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems